Author

Christopher Straub

Observed name: C Straub

Observed institution: Novartis (Switzerland)

OpenAlex ID: A5075274128

Smac mimetics: implications for enhancement of targeted therapies in leukemia

2010 · E Weisberg, A Ray, et al. · Leukemia · 93

Abstract CT073: A first-in-human study of oral TNO155 (batoprotafib) alone and in combination with EGF816 (nazartinib) in adult patients with advanced solid tumors

2025 · Chia-Chi Lin, Helena Yu, et al. · Cancer Research · 4

Abstract CT112: Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of FXX489 ([177Lu]Lu-NNS309) in patients with pancreatic, lung, breast and colorectal cancers

2025 · Ravit Geva, Daniel Juneau, et al. · Cancer Research · 2

Erratum: Smac mimetics: implications for enhancement of targeted therapies in leukemia

2011 · E Weisberg, A Ray, et al. · Leukemia · 1

Works count: 4

Citation count: 100

H-index: 2

I10-index: 1